MICHELLE PHILLIPS: Open Payments
NPI 1174976716 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 47 payments from 17 companies in 2025. Trend: 2023 $1,725 · 2024 $1,233 · 2025 $1,207
Food & beverage: $1,174Education: $32
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $276 |
| Lilly USA, LLC | 8 | $127 |
| Astellas Pharma US Inc | 5 | $125 |
| ABBVIE INC. | 6 | $120 |
| Axsome Therapeutics, Inc. | 4 | $110 |
| Novo Nordisk Inc | 5 | $98 |
| AstraZeneca Pharmaceuticals LP | 4 | $93 |
| PFIZER INC. | 4 | $69 |
| Boston Scientific Corporation | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, Veozah, VRAYLAR, Auvelity, PREVNAR 20, AIRSUPRA, REXULTI.
Industry payments across TX — which companies pay providers there.
